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ikaishun@yahoo.cAbstract We described the ﬁrst results of a quantitative ultra performance liquid chromatography–
tandem mass spectrometry method for a novel antimicrobial peptide (phylloseptin, PSN-1).
Chromatographic separation was accomplished on a Waters bridged ethyl hybrid (BEH) C18
(50 mm 2.1 mm, 1.7 mm) column with acetonitrile–water (25:75, v/v) as isocratic mobile phase.
Mass spectrometry detection was performed in the positive electrospray ionization mode and by
monitoring of the transitions at m/z 679.6/120, 509.6/120 (PSN-1) and m/z 340.7/165 (Thymopentin,
IS). Protein precipitation was investigated and the recovery was satisfactory (above 82%). The method
was shown to be reproducible and reliable with intra-day precision below 5.3%, inter-day precision
below 14.2%, and linear range from 0.02 to 2 mg/mL with r40.994. The method was successfully
applied to a pharmacokinetic study of PSN-1 in rats after intravenous administration.
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Host defense peptides are known to protect amphibians against a
variety of pathogens [1]. The skins of anurans (frogs and toads),
an important source of biologically active peptides, are regarded
as both potential key to resolve the crisis of multiple drug-
resistant strains and potential development into therapeutically
valuable pharmaceutical agents [2–4]. Phylloseptins, a new family
of antimicrobial peptides, is ﬁrstly isolated from the skin secretion
of the South American amphibian Phyllomedusa hypochondrialis,
a kind of frog native to Amazonian, Brazil, which showed a
strong antimicrobial effect against Gram-positive and Gram-
negative bacteria [5,6]. The phylloseptin (PSN-1) with a molecular
mass of 2036.44 Da (Phe-Leu-Ser-Leu-Ile-Pro-His-Ile-Val-Gly-
Val-Ala-Ser-Ile-Ala-Lys-His-Phe-amide) is a novel antimicrobial
peptide from the skin secretion of the waxy monkey frog
R.-W. Zhang et al.192Phyllomedusa sauvagei [7]. Until now, the pharmacokinetic of
phylloseptins in vivo has not been reported and the study is
necessary for therapeutically valuable pharmaceutical peptides
in the future.
In most cases, the development of immunoassays for a
peptide is a challenge because its immunogenicity is low and it
is small [8]. Recent advances in liquid chromatography–mass
spectrometry (LC–MS) techniques made LC–MS enormously
useful in polypeptide and protein analysis (e.g., determination
of molecular mass, kinetic studies, sequence analysis). How-
ever, reports on the application of LC–MS for quantitative
analysis of polypeptides/proteins in complex matrix are scarce
[9–19]. Isotope dilution (ID) was used in some methods
[9,13,14,17–19]. Indeed, because of the relative difﬁculty and
hence high cost for synthesis of stable-isotopically labeled
analogs of polypeptides, a diastereomer [15] or a homolog [16]
as internal standard was used in the measurement procedure.
In our study, an oligopeptide, thymopentin, was used as
internal standard because it was easy to obtain. The estab-
lished method was more applicable than the other methods.
Mass spectrometric analysis of PSN-1 acquired in the
positive ion mode detected a sequence of ions with m/z 509.6
([Mþ4H]4þ), m/z 679.6 ([Mþ3H]3þ), and m/z 1018.9 ([Mþ
2H]2þ), which corresponded to the quadruply, triply, and doubly
charged species, respectively. Singly charged molecular ion m/z
2037 ([MþH]þ) almost could not be detected. When choosing
one of these ions for quantitative analysis by single ion monitor-
ing (as the method reported [16]) or selective reaction monitoring,
the data generated showed unacceptable linearity in the concen-
tration range 0.02–2 mg/mL. The assay’s precision was little
improved when applying selected ion monitoring (SIM), which
combines the ion currents of all three charge states to generate a
total area under the curve (as the method [15]), but the linearity
was still good enough. Both situations were attributed to
variability in the three ions’ distribution of intensities when the
concentration of PSN-1 changed. However, after adding enough
amount acid in the PSN-1 sample solution to overcome the
variability, relative standard deviations (RSDs) and linearity were
acceptable for pharmacokinetic study. For MS/MS analysis, the
transitions at m/z 679.6/120, 509.6/120 were monitored and total
area under the curve of combined daughter ion currents was used
for calculation. To further optimize accuracy, inclusion of an
internal standard was thought to be advisable.
We reported on ﬁrst results of a quantitative method for
plasma PSN-1 that used thymopentin as internal standard,
protein precipitation for sample preparation, and UPLC-
tandem mass spectrometry (MS/MS) for fast detection. The
measurement procedure was optimized and its analytical
performance characteristics were thoroughly evaluated. Based
on the positive outcome of the latter investigations, the
method was successfully applied to a pharmacokinetic study
of PSN-1 in rats after intravenous administration.2. Materials and methods
2.1. Materials
The novel phylloseptin (PSN-1, 98% pure) with a computed
molecular mass of 2036.44 Da was synthesized by the Protein
Synthesizer (PS3 Protein Technologies, Inc.). Thymopentin
(internal standard, IS, Arg-Lys-Asp-Val-Tyr, 99.2% pure) waspurchased from the National Institute for the Control of
Pharmaceutical and Biological Products (Beijing, China).
Acetonitrile and formic acid (Tedia, Fairﬁeld, USA) were of
HPLC grade. Stock solutions were prepared by dissolving
appropriate amounts of these compounds in water. Double
distilled water was used throughout the study.
2.2. Instrumentation
Liquid chromatography was performed on a Waters Acqui-
tyTM Ultra Performance Liquid Chromatography (UPLC)
system (Waters, Milford, MA). A 6 mL aliquot of the sample
was injected into a Waters bridged ethyl hybrid (BEH) C18
(50 mm 2.1 mm, 1.7 mm) column held at 30 1C. Mass spec-
trometric detection was carried out on a Micromass Quattro
microTM API mass spectrometer (Waters Corp., Milford, MA,
USA) with an electrospray ionization (ESI) interface and
triple quadruple mass analyzer.
2.3. Sample pretreatment
Blood samples were collected from 6 rats after intravenous
administration. All the samples were then transferred into
heparinized tubes and immediately centrifuged at 3500 rpm
(890g) for 10 min. The plasma was stored at –20 1C until
utilized for the UPLC/MS/MS analysis.
To a 200 mL aliquot of plasma samples, 20 mL internal
standard solutions (2 mg/mL) was added, and then 500 mL of
acetonitrile (contain 0.2% formic acid, for increasing the
solution of PSN-1) was added for protein precipitation. The
mixture was vortexed for 1 min. After centrifugation at
11,200g for 10 min at 4 1C, the supernatant was transferred
and evaporated to dryness at 30 1C under a gentle stream of
nitrogen. The dried residue was then reconstituted in 200 mL
of 10% formic acid water (v/v). The content was transferred to
2 mL glass vials and an aliquot of 6 mL was injected for
UPLC/MS/MS analysis.
2.4. UPLC/MS/MS conditions
UPLC/MS/MS measurements were performed in the positive
electrospray tandem MS mode, i.e., monitoring the transitions
at m/z 679.6/120, 509.6/120 (total area of these two transitions
was used for calculation), and 340.7/165 (Thymopentin, IS).
The MS/MS settings were: collision energy 37 eV, cone 33 V,
for m/z 679.6/120; collision energy 27 eV, cone 27 V, for m/z
509.6/120; collision energy 19 eV, cone energy 25 V, for m/z
340.7/165. Capillary voltage was set at 3 kV. Nitrogen was
used as desolvation and cone gas with the ﬂow rate of 600 and
50 L/h, respectively.
Isocratic elution was employed with the mobile phase
composed of water and acetonitrile (75:25, v/v). The ﬂow rate
was set at 0.2 mL/min. Under these chromatographic condi-
tions, the retention time for PSN-1 and thymopentin were 1.15
and 0.71 min, respectively. Analysis time was 1.8 min for one
injection.
2.5. Analytical performance
Spiked plasma standards at seven concentrations over the
range from 0.02 to 2 mg/mL were prepared and analyzed in
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The calibration curves were constructed by weighted (1/x2)
least-squares linear regression analysis of observed PSN-1-to-
IS peak-area ratios against concentration. For the determina-
tion of LLOQ by analysis of six replicate plasma samples, the
relative standard deviation (RSD) was less than 20% and
signal-to-noise (S/N) was above 10. Quality control (QC)
samples at three concentrations (0.05, 0.2, and 1.6 mg/mL)
were analyzed to assess the precision and accuracy of the
method. Six replicates were analyzed in each of three con-
secutive analytical runs. Accuracy was expressed as relative
error (RE) and precision as relative standard deviation (RSD).
Recovery of the extraction procedure was also evaluated at
three concentration levels, by comparing the mean peak areas
(n¼6 for each concentration) obtained from plasma samples
spiked before extraction with those from plasma samples
spiked after extraction. To evaluate sample stability both after
freeze–thaw cycles and at room temperature, six replicate QC
samples at 0.05, 0.2, and 1.6 mg/mL were subjected to three
freeze–thaw cycles (20 to 25 1C) or were stored at room
temperature for 4 h before sample processing. Six replicate QC
samples at 0.05, 0.2, and 1.6 mg/mL were also processed and
stored in an autosampler for 8 h. Long-term cold storage
stability was also evaluated at three concentrations. Samples
were assumed to be stable if their bias fell within715% of the
theoretical value.
2.6. Application to pharmacokinetic study
Six male Wister rats (220–250 g) were purchased from the
Experimental Animal Center of Shenyang Pharmaceutical
University. Before drug administration, the rats were fasted
overnight. The rats were given PSN-1 intravenously (3.0 mg/kg).
Blood samples (approx. 0.5 mL) were collected from the ocular
vein before (0 h) and 0.017, 0.05, 0.083, 0.17, 0.25, 0.5, 0.75, 1,
1.5, 2, 4, 6, and 8 h after dosing. For three rats, the sampling
time was 0, 0.05, 0.17, 0.5, 1, 2, and 6 h. For the other three rats,
the sampling time was 0.017, 0.083, 0.25, 0.75, 1.5, 4, and 8 h.
All the samples were then transferred to heparinized tubes and
immediately centrifuged at 3500 rpm (890g) for 10 min. The
plasma obtained was stored at –20 1C until analysis.m/z
m/z
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Figure 1 Full scan ESIþmass spectra of PSN-1 generated in the
positive ion mode (A, without adding acid in the sample) and full
scan ESI mass spectra of thymopentin (B, adding 10% formic acid
in the sample).3. Results and discussion
3.1. Sample pretreatment and UPLC/MS/MS conditions
Acetonitrile and methanol were investigated for protein pre-
cipitation. A higher recovery achieved by using acetonitrile.
The solubility of peptide could be changed with the ﬂuctuation
of pH. PSN-1 was easily dissolved by adding 0.2% formic acid
in water and 0.2% formic acid in acetonitrile was responsible
for the increase of solubility.
In ESI negative ion mode, any charged molecular ions of
PSN-1 almost could not be used for quantitation in this study,
so ESI positive ion mode was employed. In current study,
without adding acid in the sample, stably charged ions using
0.2% formic acid in mobile phase were investigated. It was
found stably quadruply or triply charged ions were not
produced and the linearity did not meet the criterion of
pharmacokinetic study. While in the method reported [20],
0.2% formic acid in mobile phase is enough to produce stablydoubly charged ions. The reason may be that the molecular
weight of PSN-1 is much higher than that of Ximelagatran in
the reported method [20]. PSN-1 was more complicated and
0.2% formic acid in mobile phase could not produce stably
quadruply or triply charged ions.
Without adding acid in the sample for injecting into the
UPLC/MS/MS system, full scan ESI mass spectra (m/z 100–2048)
were generated in the positive ion mode and showed the
quadruply, triply, and doubly charged molecular ions of PSN-1
with m/z 509.6 ([Mþ4H]4þ), m/z 679.6 ([Mþ3H]3þ), and m/z
1018.9 ([Mþ2H]2þ). Singly charged molecular ion m/z 2037.6
([MþH]þ) almost could not be found (Fig. 1A).
In ESI-MS analysis, lowering the pH of the sample by
addition of formic or acetic acid (ca. 1–10%) favors the
ionization process by enhancing the degree of protonation of
peptides in solution [21]. After adding enough amount acid in
the PSN-1 sample solution to overcome the variability, RSD
and linearity were acceptable.
After adding 10% formic acid in the reconstitution solu-
tion, m/z 509.6 ([Mþ4H]4þ), m/z 679.6 ([Mþ3H]3þ) could be
found in the full scan ESI mass spectra, and the intensity of
quadruply charged ion was twice as much as that of triply
charged ion. The quintuply and doubly charged molecular
ions (m/z 408.2, m/z 1018.9) almost could not be detected.
Internal standard thymopentin with m/z 227.2 ([Mþ3H]3þ),
m/z 340.7 ([Mþ2H]2þ), and m/z 680.9([MþH]þ) (Fig. 1B) was
R.-W. Zhang et al.194shown in the mass spectra, only m/z 340.7 was chosen as
parent ion.
Mass spectrometric analysis of PSN-1 acquired in the
positive ion mode, and the transitions monitored were m/z
509.6/120 ([Mþ4H]4þ) and m/z 679.6/120 ([Mþ3H]3þ). When
choosing one of them for quantitative analysis by selective
reaction monitoring(SRM), the data generated showed RSDs
were not good enough. However, the assay’s precision was
signiﬁcantly improved when the daughter ion currents of two
charged states were combined to generate a total area. The
typical multiple reaction monitoring (MRM) chromatograms
are shown in Fig. 2. By comparing the ratio of peak areas of
two ion species in selected reaction monitoring (SRM) mode
with that in selected ion monitoring (SIM) mode, the ratios
were the same in different mode. When the concentration was
0.05 mg/mL, the ratios of peak area of 4þ to that of 3þ ions
were about 1.7 in both modes. When the concentration was
1.6 mg/mL, the ratios were about 1.1 in both modes. Speciﬁcity
for SRM was better than that for SIM, so SIM mode was
replaced by SRM mode.
The investigation of linearity was the key for the determi-
nation of PSN-1. When choosing one of charged ions for
quantitative analysis by single ion monitoring or selective
reaction monitoring, or combining the ion currents of allTime
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Figure 2 MRM chromatograms of blank plasma (A), blank plasma
LLOQ) and thymopentin (m/z 340.7/165, IS) (B), and subject plasma sacharge states to generate a total area under the curve in our
study, the data generated showed unacceptable linearity over
the concentration range 0.02–2 mg/mL. Both situations were
attributed to variability in the each ion’s distribution of
intensities when the concentration of PSN-1 changed and
pH played an important role in the distribution of intensities.
For the example in our study, 0.2 and 2 mg/mL PSN-1 were
prepared in 0.2% formic acid, respectively, and m/z 679.6/120
([Mþ3H]3þ) was chosen for quantitative analysis by single ion
monitoring, the peak area of 2 mg/mL PSN-1 was only about
three times as much as that of 0.2 mg/mL PSN-1 under the
same UPLC/MS condition, though the ten times of concen-
tration existed between two samples. The RSD% of peak
areas of PSN-1 was not acceptable. The concentration of
formic acid in reconstitution solution was investigated. The
different concentrations of peptide (PSN-1) in 0%, 0.2%, 2%,
5%, 8%, and 10% (v/v) formic acid water were injected into
the UPLC/MS/MS system. When 10% formic acid was
applied, the linearity was best among them. Larger amount
of formic acid was not investigated and 10% formic acid was
not used in the mobile phase, because low pH could do harm
to the column and mass system.
The peak of PSN-1 was divided to 2 peaks, which was due
to the difference between reconstitution solution and mobile0
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mple obtained from a rat 2 h after intravenous administration (C).
Quantitative analysis of a novel antimicrobial peptide in rat plasma 195phase [22]. The peak ahead was much smaller than the behind
and the retention time was 0.61 and 1.16 min, respectively.
The total area of 2 peaks was used for calculation.
3.2. Calibration and assay validation
Spiked plasma standards at six concentrations over the range
0.02–2 mg/mL were prepared and analyzed in three consecutive
analytical runs, with two groups in each run. The calibration
plots were constructed by weighted (1/x2) least-squares linear
regression analysis of observed peptide-to-IS peak-area ratios
against concentration. The mean regression equation for the
calibration plot was y¼11.99x0.135, with a correlation
coefﬁcient 40.994. Analysis of six replicate plasma samples
showed the LLOQ of the method was 0.02 mg/mL, S/N was
above 10 and the RSD was 12.9%. Quality control (QC)
samples at three concentrations (0.05, 0.2, and 1.6 mg/mL)
were analyzed to assess the precision and accuracy of the
method. Six replicates were analyzed in each of three con-
secutive analytical runs. Accuracy was expressed as RE and
precision as RSD. Recovery of the extraction procedure was
also evaluated at three concentrations, by comparing the mean
peak areas (n¼6 for each concentration) obtained from
plasma samples spiked before extraction with those from
plasma samples spiked after extraction.
The result listed in Table 1 was indicative of good analytical
characteristics of the assay. To evaluate sample stability both
after freeze–thaw cycles and at room temperature, six replicate
QC samples at 0.05, 0.2, and 1.6 mg/mL were subjected to
three freeze–thaw cycles (20 to 25 1C) or were stored at room
temperature for 4 h before sample processing. Six replicate QCTable 1 Precision, accuracy, and recovery for the determination
Concentration (mg/mL) RSD (%)
Added Found (mean) Intra-assay
0.05 0.048 5.2
0.2 0.19 5.3
1.6 1.49 3.6
Table 2 Summary of stability of PSN-1 in rats plasma (n¼6).
Stability Concentration added
0.05 mg/mL 0.2 mg/m
Found
(mean,
mg/mL)
Precision
(RSD, %)
Accuracy
(RE, %)
Found
(mean,
mg/mL)
Three freeze–thaw
cycles
0.050 9.9 0.8 0.207
Short term (room
temperature for 4 h)
0.053 2.3 5.2 0.189
Long term (20 1C for
10 days)
0.048 4.4 4.9 0.180
Post-preparative
(25 1C for 8 h)
0.049 3.7 1.2 0.183samples at 0.05, 0.2, and 1.6 mg/mL were also processed and
stored in an autosampler for 8 h. Long-term cold storage
stability was also evaluated at three concentrations. Samples
were assumed to be stable if their bias fell within715% of the
actual value. Results from testing of the freeze–thaw, short-
term, post-preparative, and long-term stability of peptide,
summarized in Table 2, showed that peptide is sufﬁciently
stable under these conditions.
Suppression of ionization was evaluated by comparing the
absolute peak area from a control plasma sample extracted and
then spiked with a known amount of analyte, to that of a neat
standard prepared in the same reconstitution solvent. The samples
at 0.05, 0.2, and 1.6 mg/mL concentrations were analyzed. The
ratios of the absolute peak area at the same concentration were
within 0.94–1.06. The results showed that the inﬂuence of the
matrix effect could be ignored. 10% formic acid in reconstitution
solvent had a positive effect on the ionization of PSN-1.
3.3. Pharmacokinetic study of PSN-1 in rats
The plasma concentrations of PSN-1 at different time are
expressed as mean7SD, and mean concentration–time curve
was plotted (Fig. 3).
All of the pharmacokinetic data listed in Table 3 were
obtained on the basis of non-compartmental analysis (DAS 2.1
statistical software; Pharmacology Institute of China). Pharma-
cokinetic study of PSN-1 in rats after intravenous administration
was investigated. A complete plasma concentration–time curve
was obtained. The fate of PSN-1 in rats after intravenous
administration (3.0 mg/kg) was indicative of fast elimination
process with t1/2 of 2.08 h.of PSN-1 in rat plasma (n¼6).
RE (%) Recovery (%)
Inter-assay
14.2 3.1 89.5711.1
12.9 4.6 86.576.1
10.3 7.0 82.475.1
L 1.6 mg/mL
Precision
(RSD, %)
Accuracy
(RE, %)
Found
((mean,
mg/mL)
Precision
(RSD, %)
Accuracy
(RE, %)
8.7 3.4 1.579 7.4 1.3
3.7 5.5 1.515 4.9 5.3
5.6 10.1 1.571 2.7 1.8
2.9 8.6 1.535 2.1 4.1
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Figure 3 Mean plasma concentration–time proﬁle after intra-
venous administration of PSN-1 to rats (n¼6).
Table 3 Pharmacokinetic data in rats after intravenous
administration of 3.0 mg/kg PSN-1 (n¼6).
Parameter Estimate (mean7SD)
tmax (h) 0.01770
Cmax (mg/mL) 1.2970.34
t1/2 (h) 2.0870.31
Vd (L/kg) 5.2370.84
Clp [L/(h kg)] 1.78270.405
AUC0t (mg h/mL) 1.65870.356
AUC0N (mg h/mL) 1.75970.404
R.-W. Zhang et al.1964. Conclusions
A new method had been established for analysis of PSN-1 in
plasma. The recovery of the method was satisfactory (in the
range 82–90%). This method is especially suitable for deter-
mination of peptide from biological matrixes. Combined with
UPLC/MS/MS detection, it can be highly effective in the
extraction and analysis of peptide from rat plasma. Pharma-
cokinetic study was necessary for more and more therapeuti-
cally active peptides in the future. This method has been
shown to enable simple, rapid, and reliable assay of peptide in
biological samples.
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